Extended Data Fig. 2: Outline of the participant selection process in the no-RAT external cohort.
From: Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
Patients from the EP-SEASON study who met the same eligibility criteria as the EP-STAR trial and received SOC without modifications were included as a pre-planned non-randomized external cohort for efficacy comparison.
